Companies Hims & Hers Health
Hims & Hers Health (HIMS): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Hims & Hers Health’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $14,401,411FY2023
- $24,609,077FY2024
- $22,958,907FY2025
CEO total pay was $22,958,907 in fiscal 2025, down from $24,609,077 in fiscal 2024.
FY2025: salary $494,792 · bonus $0 · stock awards $10,635,352 · option awards $11,000,000
Executives and directors
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Mohamed Elshenawy | $375,000 | $3,000,000 | $57,216,276 | $0 | $278,470 | $0 | $0 | $60,869,746 |
| Chief Technology Officer | ||||||||
| Andrew Dudum | 494,792 | 0 | 10,635,352 | 11,000,000 | 585,763 | 0 | 243,000 | 22,958,907 |
| Chief Executive Officer and Chairman | ||||||||
| Nader Kabbani | 227,273 | 1,000,000 | 13,486,199 | 0 | 0 | 0 | 148,833 | 14,862,305 |
| Former Chief Operating Officer | ||||||||
| Yemi Okupe | 530,875 | 0 | 7,473,689 | 0 | 376,763 | 0 | 17,481 | 8,398,808 |
| Chief Financial Officer | ||||||||
| Melissa Baird | 341,292 | 0 | 8,048,579 | 0 | 0 | 0 | 3,000 | 8,392,871 |
| Former Chief Operating Officer | ||||||||
| Mike Chi | 485,000 | 0 | 6,898,799 | 0 | 340,914 | 0 | 3,000 | 7,727,713 |
| Chief Operating Officer (previously Chief Commercial Officer) | ||||||||
| Soleil Boughton | 464,375 | 0 | 4,024,269 | 0 | 305,065 | 0 | 3,000 | 4,796,709 |
| Chief Legal Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Mohamed Elshenawy | $60,869,746 | — | — | — |
| Andrew Dudum | 22,958,907 | 24,609,077 | 14,401,411 | ↓ −1,650,170 |
| Nader Kabbani | 14,862,305 | — | — | — |
| Yemi Okupe | 8,398,808 | 8,196,173 | 7,432,394 | ↑ +202,635 |
| Melissa Baird | 8,392,871 | 9,083,971 | 6,765,760 | ↓ −691,100 |
| Mike Chi | 7,727,713 | 7,008,181 | 6,709,160 | ↑ +719,532 |
| Soleil Boughton | 4,796,709 | 4,673,336 | 5,212,071 | ↑ +123,373 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Our executive compensation programs are designed to attract, reward and retain our named executive officers, who are vital to the success of our Company. Our programs reward our named executive officers for achieving specific annual and strategic goals.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Compensia, Inc. |
| Clawback policy | true |
| Anti-hedging | True |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Nader Kabbani | RSU | 2025-05-19 | — | — | 216,333 | — | $13,486,199 |
| Mohamed Elshenawy | RSU | 2025-05-12 | — | — | 1,036,339 | — | 57,216,276 |
| Yemi Okupe | RSU | 2025-03-03 | — | — | 183,719 | — | 7,473,689 |
| Mike Chi | RSU | 2024-02-28 | — | — | 169,587 | — | 6,898,799 |
| Andrew Dudum | RSU | 2025-03-11 | — | — | 306,406 | — | 10,635,352 |
| Mike Chi | RSU | 2025-03-03 | — | — | 169,587 | — | 6,898,799 |
| Melissa Baird | RSU | 2025-03-03 | — | — | 197,851 | — | 8,048,579 |
| Soleil Boughton | RSU | 2025-03-03 | — | — | 98,925 | — | 4,024,269 |
| Andrew Dudum | OPTION | 2025-03-11 | 278,622 | 557,244 | — | 1,393,110 | 11,000,000 |
| Yemi Okupe | RSU | 2024-02-28 | — | — | 183,719 | — | 7,473,689 |
| Yemi Okupe | RSU | 2025-03-03 | — | — | 183,719 | — | 7,473,689 |
| Mike Chi | RSU | 2025-03-03 | — | — | 169,587 | — | 6,898,799 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Nader Kabbani | $13,486,199 | $0 | $0 | 0.0% |
| Mohamed Elshenawy | 57,216,276 | 0 | 0 | 0.0% |
| Yemi Okupe | 22,421,067 | 0 | 0 | 0.0% |
| Mike Chi | 20,696,397 | 0 | 0 | 0.0% |
| Andrew Dudum | 10,635,352 | 0 | 11,000,000 | 0.0% |
| Melissa Baird | 8,048,579 | 0 | 0 | 0.0% |
| Soleil Boughton | 4,024,269 | 0 | 0 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Mike Chi | RSU | 9,357 | — | $303,822 |
| Soleil Boughton | RSU | 10,916 | — | 354,443 |
| Melissa Baird | RSU | 18,713 | — | 607,611 |
| Yemi Okupe | Option | 21,486 | 5.01 | — |
| Soleil Boughton | Option | 23,110 | 11.53 | — |
| Mike Chi | Option | 30,814 | 11.53 | — |
| Melissa Baird | Option | 30,814 | 11.53 | — |
| Mike Chi | Option | 34,608 | 5.01 | — |
| Yemi Okupe | Option | 34,665 | 11.53 | — |
| Andrew Dudum | RSU | 35,242 | — | 1,144,308 |
| Soleil Boughton | Option | 40,376 | 5.01 | — |
| Andrew Dudum | Option | 43,451 | 5.01 | — |
| Mike Chi | RSU | 49,487 | — | 1,606,843 |
| Yemi Okupe | RSU | 52,396 | — | 1,701,298 |
| Mike Chi | Option | 58,072 | 6.82 | — |
| Soleil Boughton | RSU | 61,115 | — | 1,984,404 |
| Andrew Dudum | Option | 67,020 | 11.53 | — |
| Melissa Baird | Option | 69,215 | 5.01 | — |
| Soleil Boughton | RSU | 80,377 | — | 2,609,841 |
| Mike Chi | RSU | 81,487 | — | 2,645,883 |
| Melissa Baird | RSU | 81,487 | — | 2,645,883 |
| Soleil Boughton | PSU | 82,964 | — | 2,693,841 |
| Yemi Okupe | RSU | 91,672 | — | 2,976,590 |
| Soleil Boughton | RSU | 108,891 | — | 3,535,691 |
| Mike Chi | PSU | 132,743 | — | 4,310,165 |
| Soleil Boughton | PSU | 136,897 | — | 4,445,046 |
| Mike Chi | RSU | 137,790 | — | 4,474,041 |
| Yemi Okupe | RSU | 149,272 | — | 4,846,862 |
| Yemi Okupe | PSU | 157,632 | — | 5,118,311 |
| Melissa Baird | RSU | 160,754 | — | 5,219,682 |
| Mike Chi | RSU | 174,226 | — | 5,657,118 |
| Andrew Dudum | RSU | 177,233 | — | 5,754,756 |
| Mike Chi | PSU | 182,529 | — | 5,926,717 |
| Melissa Baird | PSU | 182,529 | — | 5,926,717 |
| Yemi Okupe | PSU | 205,345 | — | 6,667,552 |
| Yemi Okupe | RSU | 206,893 | — | 6,717,816 |
| Nader Kabbani | RSU | 216,333 | — | 7,024,333 |
| Melissa Baird | RSU | 235,205 | — | 7,637,106 |
| Andrew Dudum | RSU | 248,955 | — | 8,083,569 |
| Andrew Dudum | PSU | 397,001 | — | 12,890,622 |
| Andrew Dudum | PSU | 511,061 | — | 16,594,151 |
| Andrew Dudum | Option | 521,410 | 5.01 | — |
| Andrew Dudum | Option | 557,244 | 34.71 | — |
| Andrew Dudum | RSU | 670,769 | — | 21,779,869 |
| Mohamed Elshenawy | RSU | 1,036,339 | — | 33,649,927 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Deb AutorIndependent · Audit · Compensation · Nominating/Governance · Partial-year service | $44,000 | $186,931 | $0 | $0 | $75,000 | $305,931 |
| David WellsIndependent · Lead Independent Director · Audit · Compensation · Nominating/Governance | 87,648 | 186,931 | 0 | 0 | 0 | 274,579 |
| Christopher PayneIndependent · Audit · Compensation · Nominating/Governance | 59,148 | 186,931 | 0 | 0 | 0 | 246,079 |
| Andrea PerezIndependent · Audit (Chair) · Compensation · Nominating/Governance | 55,000 | 186,931 | 0 | 0 | 0 | 241,931 |
| Anja ManuelIndependent · Audit · Compensation (Chair) · Nominating/Governance | 54,000 | 186,931 | 0 | 0 | 0 | 240,931 |
| Christiane PendarvisIndependent · Audit · Compensation · Nominating/Governance (Chair) · Not standing for re-election · Departed during FY | 50,000 | 186,931 | 0 | 0 | 0 | 236,931 |
| Kåre SchultzIndependent · Audit · Compensation · Nominating/Governance · Partial-year service | 44,000 | 186,931 | 0 | 0 | 0 | 230,931 |
| Delos CosgroveIndependent · Audit · Compensation · Nominating/Governance | 40,000 | 186,931 | 0 | 0 | 0 | 226,931 |
| Patrick CarrollNot independent · Audit · Compensation · Nominating/Governance · Not standing for re-election · Departed during FY | 40,000 | 186,931 | 0 | — | 0 | 226,931 |
| Andrew DudumEmployee director · Board Chair | 0 | 0 | 0 | — | 0 | 0 |
| Kofi Amoo-GottfriedIndependent · Audit · Compensation · Nominating/Governance · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | $200,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 15,000 / 8,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $473,796 |
| Equity awards (grant-date value) | $1,682,379 |
| All other compensation | $75,000 |
| Total cost of the board | $2,231,175 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Hims & Hers Health as a peer
Companies that benchmark against HIMS
6 companies name HIMS as a compensation peer
- Accolade, Inc.ACCDFY2024
- Astrana Health, Inc.ASTHFY2025
- Chrome Holding Co.MEFY2024
- GoodRx Holdings, Inc.GDRXFY2025
- LifeStance Health Group, Inc.LFSTFY2025
- SkinHealth Systems Inc.SKINFY2025
Each company listed discloses HIMS in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named HIMS in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Peer reciprocity
Of the companies Hims & Hers Health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Hims & Hers Health.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Alteryx | 2022 | Mark Anderson | $650,000 | $55,823,051 | $0 | $650,000 | $57,191,521 |
| 2 | Elastic NV | 2026 | Ashutosh Kulkarni | 750,000 | 45,343,687 | 0 | 832,532 | 46,961,904 |
| 3 | Coursera | 2025 | Gregory Hart | 540,833 | 14,629,466 | 23,644,105 | 570,467 | 39,387,371 |
| 4 | Hims & Hers Health | 2025 | Andrew Dudum | 494,792 | 10,635,352 | 11,000,000 | 585,763 | 22,958,907 |
| 5 | Five9 | 2025 | Michael Burkland | 585,000 | 16,186,638 | 0 | 621,270 | 17,403,709 |
| 6 | PagerDuty | 2026 | Jennifer Tejada | 600,000 | 14,219,766 | 0 | 347,760 | 15,268,028 |
| 7 | Privia Health Group | 2025 | Parth Mehrotra | 650,000 | 8,588,373 | 0 | 1,218,750 | 10,472,698 |
| 8 | Yelp | 2025 | Jeremy Stoppelman | 620,000 | 9,104,111 | 0 | 500,444 | 10,256,932 |
| 9 | Smartsheet | 2024 | Mark P. Mader | 587,077 | 9,085,222 | 0 | 511,134 | 10,205,886 |
| 10 | Rapid7 | 2025 | Corey Thomas | 545,000 | 9,195,576 | 0 | 315,000 | 10,058,576 |
| 11 | CarGurus | 2025 | Jason Trevisan | 647,500 | 6,499,975 | 0 | 709,325 | 7,889,260 |
| 12 | Bumble | 2025 | Whitney Wolfe Herd | 650,000 | 6,303,827 | 0 | 650,000 | 7,617,828 |
| 13 | Jamf Holding | 2024 | John Strosahl | 550,001 | 5,999,997 | 0 | 539,000 | 7,106,371 |
| 14 | Udemy | 2024 | Greg Brown | 583,750 | 4,548,838 | 0 | 0 | 5,151,396 |
| 15 | Sprinklr | 2026 | Rory Read | 675,000 | 0 | 0 | 985,500 | 1,664,700 |
| 16 | DigitalOcean | 2025 | Padmanabhan Srinivasan | 600,000 | 0 | 0 | 588,000 | 1,210,795 |
| 17 | EngageSmart | 2022 | Robert Bennett | 600,000 | 0 | 0 | 357,000 | 958,500 |
| 18 | Duolingo | 2025 | Luis von Ahn | 750,000 | 0 | 0 | 0 | 767,500 |
| 19 | Box | 2026 | Aaron Levie | 162,000 | 0 | 0 | 94,912 | 257,076 |
| — | SentinelOne | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Hims & Hers Health | 93.72% | Options 51 · RSU 49 | No | Compensia, Inc. |
| Alteryx | 100% | RSU 75 · PSU 25 | No | Alpine Rewards |
| Box | 105.5% | RSU 50 · PSU 50 | not disclosed | Compensia |
| Bumble | not disclosed | RSU 100 | not disclosed | Semler Brossy |
| CarGurus | 108.29% | RSU 100 | not disclosed | Compensia, Inc. |
| Coursera | 106.3% | RSU 75 · PSU 25 | No | Compensia |
| DigitalOcean | 98% | PSU 65 · RSU 35 | No | Compensia |
| Duolingo | not disclosed | PSU 100 | No | Compensia, Inc. |
| Elastic NV | not disclosed | PSU 50 · RSU 50 | No | Semler Brossy Consulting Group LLC |
| EngageSmart | not disclosed | not disclosed | not disclosed | Compensia, Inc. |
| Five9 | 106% | RSU 50 · PSU 50 | Yes — Relative Total Shareholder Return (RTSR) versus the companies of the S&P Software and Services Select Index | Compensia |
| Jamf Holding | not disclosed | RSU 100 | not disclosed | Radford |
| PagerDuty | 58.0% | PSU 50 · RSU 50 | No | Compensia, Inc. |
| Privia Health Group | 150% | PSU 60 · RSU 40 | No | Korn Ferry (through September 2025), WTW (starting September 2025) |
| Rapid7 | 50% | RSU 50 · PSU 50 | No | Compensia |
| SentinelOne | 96% | RSU 60 · PSU 40 | No | Aon |
| Smartsheet | 87.4% | PSU 50 · RSU 50 | No | Compensia |
| Sprinklr | 146.7% | RSU 75 · PSU 25 | Yes — Relative Total Stockholder Return (rTSR) | Compensia |
| Udemy | not disclosed | RSU 50 · PSU 50 | No | FW Cook |
| Yelp | 100.9% | not disclosed | Yes — Relative TSR vs Russell 2000 | Compensia, Inc. |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-11 | 1,506,477,171 | 11,181,420 | 309,881 | 99.26% | Passed |
| 2025 | 2025-06-12 | 1,528,328,634 | 26,472,285 | 309,795 | 98.3% | Passed |
| 2024 | 2024-06-06 | 1,517,206,862 | 42,457,770 | 671,873 | 97.28% | Passed |
| 2023 | 2023-06-01 | 1,529,000,617 | 16,445,485 | 436,802 | 98.94% | Passed |
| 2022 | 2022-06-02 | 1,525,451,481 | 3,204,466 | 725,386 | 99.79% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-06-11 | 99.26%a |
| 2025 | 2025-06-12 | 98.3%b |
| 2024 | 2024-06-06 | 97.28%c |
a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will be counted as present for purposes of determining the presence of a quorum but will not be considered as votes cast for or against this proposal and will therefore have no effect on the outcome of the vote.”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will be counted as present for purposes of determining the presence of a quorum but will not be considered as votes cast for or against this proposal and will therefore have no effect on the outcome of the vote.”.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes will be counted as present for purposes of determining the presence of a quorum but will not be considered as votes cast for or against this proposal and will therefore have no effect on the outcome of the vote.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 272 : 1 |
|---|---|
| CEO total compensation | $22,958,907 |
| Median employee compensation | $84,402 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Yemi Okupe | Chief Financial Officer | 2026-05-18 | D | 7,950 | $24 | $187,916 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-05-18 | D | 7,950 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-05-18 | A | 7,950 | 5 | 39,830 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-05-20 | — | 2,039 | — | — | 3 insiders, 3 accrual rows | ||
| David Wells | Director | 2026-05-26 | A | 48,400 | 24 | 1,172,974 | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Delos Cosgrove | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Delos Cosgrove | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Christiane Pendarvis | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christiane Pendarvis | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Deb Autor | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Andrea Perez | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrea Perez | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Kåre Schultz | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| David Wells | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-15 | D | 10,040 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-06-15 | — | 3,431 | — | — | 4 insiders, 4 accrual rows | ||
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 47,699 | 30 | 1,439,079 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 18,811 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 11,483 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 22,988 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 18,334 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 39,541 | 30 | 1,192,952 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | A | 71,616 | — | — | Common | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-15 | A | 10,040 | — | — | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 25,865 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | A | 25,926 | — | — | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 11,756 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 6,183 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 12,099 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 12,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 23,315 | 30 | 703,414 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | A | 42,261 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-15 | D | 15,396 | 30 | 464,497 | Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | D | 10,040 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | A | 647 | — | — | RSU | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | A | 10,040 | — | — | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | A | 435 | — | — | RSU | Form 4 ↗ |
| David Wells | Director | 2026-06-15 | A | 957 | — | — | RSU | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | D | 23,513 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | D | 259,084 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | D | 151,534 | 30 | 4,571,781 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | A | 282,597 | — | — | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 19,150 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 74,530 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 35,446 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 85,632 | 30 | 2,583,517 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | A | 154,991 | — | — | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 3,879 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 4,344 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 4,065 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 2,291 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 5,870 | 30 | 177,098 | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | A | 15,971 | — | — | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 23,514 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 10,599 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 19,358 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 16,297 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 16,496 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | A | 86,264 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-15 | D | 32,919 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-15 | A | 32,919 | — | — | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 9,405 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 3,533 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 4,840 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 8,148 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 8,310 | 30 | 250,713 | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-16 | D | 7,573 | 30 | 229,083 | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-17 | D | 14,027 | 32 | 441,851 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-17 | D | 30,040 | 32 | 946,260 | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-17 | D | 4,490 | 32 | 141,435 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-18 | D | 55,383 | 35 | 1,943,389 | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-18 | D | 23,726 | 35 | 830,410 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-22 | A | 6,376 | 5 | 31,944 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-22 | D | 6,376 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-22 | D | 18,197 | 34 | 619,217 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-06 | D | 7,163 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-06 | D | 7,163 | 36 | 261,351 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-06 | A | 7,163 | 5 | 35,887 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-17 | D | 7,163 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-17 | D | 7,163 | 32 | 229,168 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-17 | A | 7,163 | 5 | 35,887 | Common | Form 4 ↗ |
| Delos Cosgrove | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-12 | — | 1,583 | — | — | 3 insiders, 3 accrual rows | ||
| Kofi Amoo-Gottfried | Director | 2026-08-12 | A | 13,157 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrea Perez | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kofi Amoo-Gottfried | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Anja Manuel | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-12 | A | 1,200,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 11,482 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 22,988 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 78,859 | 28 | 2,219,881 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 21,500 | 28 | 605,225 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | A | 42,261 | — | — | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-14 | — | 2,977 | — | — | 4 insiders, 4 accrual rows | ||
| Irene Becklund | PAO | 2026-08-14 | D | 4,066 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 23,514 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 16,297 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 47,702 | 28 | 1,342,811 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 35,447 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 36,437 | 28 | 1,025,702 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | A | 71,616 | — | — | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 18,335 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 6,490 | 28 | 182,694 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 100,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | A | 188,285 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-14 | A | 32,920 | — | — | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 23,514 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | A | 154,993 | — | — | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | A | 25,927 | — | — | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 11,757 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 6,182 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 12,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 12,099 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-08-14 | A | 545 | — | — | RSU | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 3,880 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 4,345 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | A | 13,685 | — | — | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 64,771 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 95,798 | 28 | 2,696,714 | Common | Form 4 ↗ |
| David Wells | Director | 2026-08-14 | A | 778 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-14 | D | 32,920 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 10,600 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 19,358 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 16,496 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | A | 86,265 | — | — | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 25,865 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 19,151 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 74,530 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 9,406 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 3,533 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 4,839 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 8,149 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 10,201 | 28 | 287,158 | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | A | 260 | — | — | Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-08-14 | D | 6,623 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-08-14 | A | 6,623 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-14 | D | 16,147 | 28 | 454,538 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 18,811 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-17 | D | 9,388 | 28 | 261,802 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-17 | D | 9,388 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-17 | A | 9,388 | 5 | 47,034 | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-18 | D | 16,773 | 28 | 467,128 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-19 | D | 4,938 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-19 | D | 4,938 | 30 | 148,111 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-19 | A | 4,938 | 5 | 24,739 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-19 | D | 25,111 | 28 | 691,808 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-25 | D | 463,289 | 0 | 0 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-27 | D | 977,566 | 0 | 0 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-09-02 | D | 3,458 | 28 | 97,965 | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-09-15 | D | 14,027 | 28 | 398,227 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-09-15 | D | 7,954 | 28 | 225,814 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-09-16 | D | 6,236 | 28 | 173,735 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-17 | D | 12,313 | 29 | 354,861 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-22 | D | 14,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-22 | D | 29,277 | 30 | 876,846 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-22 | A | 14,000 | 5 | 70,140 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-09-30 | D | 3,461 | 29 | 100,957 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-10-01 | D | 2,000 | 30 | 59,400 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-10-14 | D | 3,461 | 29 | 100,577 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-10-28 | D | 3,462 | 28 | 95,551 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
View all 183 transactions
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Yemi Okupe | Chief Financial Officer | 2026-05-18 | D | 7,950 | $24 | $187,916 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-05-18 | D | 7,950 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-05-18 | A | 7,950 | 5 | 39,830 | Common | Form 4 ↗ |
| Patrick Carroll | Director | 2026-05-20 | A | 435 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-05-20 | A | 957 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-05-20 | A | 647 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-05-26 | A | 48,400 | 24 | 1,172,974 | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Delos Cosgrove | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Delos Cosgrove | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Christiane Pendarvis | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christiane Pendarvis | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Deb Autor | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Andrea Perez | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrea Perez | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Kåre Schultz | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| David Wells | Director | 2026-06-11 | D | 3,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-06-11 | A | 3,656 | — | — | RSU | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-15 | D | 10,040 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-06-15 | D | 957 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 435 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 47,699 | 30 | 1,439,079 | Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | D | 647 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 18,811 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 11,483 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 22,988 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 18,334 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | D | 39,541 | 30 | 1,192,952 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-15 | A | 71,616 | — | — | Common | Form 4 ↗ |
| Anja Manuel | Director | 2026-06-15 | A | 10,040 | — | — | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 25,865 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | A | 25,926 | — | — | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 11,756 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 6,183 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 12,099 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 12,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | D | 23,315 | 30 | 703,414 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-06-15 | A | 42,261 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-15 | D | 15,396 | 30 | 464,497 | Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | D | 10,040 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | A | 647 | — | — | RSU | Form 4 ↗ |
| Christopher Payne | Director | 2026-06-15 | A | 10,040 | — | — | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | A | 435 | — | — | RSU | Form 4 ↗ |
| David Wells | Director | 2026-06-15 | A | 957 | — | — | RSU | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | D | 23,513 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | D | 259,084 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | D | 151,534 | 30 | 4,571,781 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-15 | A | 282,597 | — | — | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 19,150 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 74,530 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 35,446 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | D | 85,632 | 30 | 2,583,517 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-06-15 | A | 154,991 | — | — | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 3,879 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 1,392 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 4,344 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 4,065 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 2,291 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | D | 5,870 | 30 | 177,098 | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-15 | A | 15,971 | — | — | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 23,514 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 10,599 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 19,358 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 16,297 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | D | 16,496 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-15 | A | 86,264 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-15 | D | 32,919 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deb Autor | Director | 2026-06-15 | A | 32,919 | — | — | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 9,405 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 3,533 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 4,840 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 8,148 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-15 | D | 8,310 | 30 | 250,713 | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-16 | D | 7,573 | 30 | 229,083 | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-06-17 | D | 14,027 | 32 | 441,851 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-06-17 | D | 30,040 | 32 | 946,260 | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-06-17 | D | 4,490 | 32 | 141,435 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-18 | D | 55,383 | 35 | 1,943,389 | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-06-18 | D | 23,726 | 35 | 830,410 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-22 | A | 6,376 | 5 | 31,944 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-22 | D | 6,376 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-06-22 | D | 18,197 | 34 | 619,217 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-06 | D | 7,163 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-06 | D | 7,163 | 36 | 261,351 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-06 | A | 7,163 | 5 | 35,887 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-17 | D | 7,163 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-17 | D | 7,163 | 32 | 229,168 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-07-17 | A | 7,163 | 5 | 35,887 | Common | Form 4 ↗ |
| Delos Cosgrove | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-12 | A | 260 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kofi Amoo-Gottfried | Director | 2026-08-12 | A | 13,157 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrea Perez | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-08-12 | A | 778 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kofi Amoo-Gottfried | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Anja Manuel | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-08-12 | A | 545 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-08-12 | A | 8,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-12 | A | 1,200,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 11,482 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 22,988 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 78,859 | 28 | 2,219,881 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 21,500 | 28 | 605,225 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | A | 42,261 | — | — | Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 1,394 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 4,066 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 23,514 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 16,297 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 47,702 | 28 | 1,342,811 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 35,447 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 36,437 | 28 | 1,025,702 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | A | 71,616 | — | — | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 18,335 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 6,490 | 28 | 182,694 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 100,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | A | 188,285 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-14 | A | 32,920 | — | — | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 23,514 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | A | 154,993 | — | — | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | A | 25,927 | — | — | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 11,757 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 6,182 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 12,223 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-14 | D | 12,099 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-08-14 | D | 545 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher Payne | Director | 2026-08-14 | A | 545 | — | — | RSU | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 3,880 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | D | 4,345 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Irene Becklund | PAO | 2026-08-14 | A | 13,685 | — | — | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 64,771 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-08-14 | D | 95,798 | 28 | 2,696,714 | Common | Form 4 ↗ |
| David Wells | Director | 2026-08-14 | D | 778 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Wells | Director | 2026-08-14 | A | 778 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-14 | D | 32,920 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 10,600 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 19,358 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | D | 16,496 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-08-14 | A | 86,265 | — | — | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 25,865 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 19,151 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-14 | D | 74,530 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 9,406 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 3,533 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 4,839 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 8,149 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 260 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | D | 10,201 | 28 | 287,158 | Common | Form 4 ↗ |
| Patrick Carroll | Chief Medical Officer | 2026-08-14 | A | 260 | — | — | Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-08-14 | D | 6,623 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kåre Schultz | Director | 2026-08-14 | A | 6,623 | — | — | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-14 | D | 16,147 | 28 | 454,538 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-14 | D | 18,811 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-17 | D | 9,388 | 28 | 261,802 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-17 | D | 9,388 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-17 | A | 9,388 | 5 | 47,034 | Common | Form 4 ↗ |
| Deb Autor | Director | 2026-08-18 | D | 16,773 | 28 | 467,128 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-19 | D | 4,938 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-19 | D | 4,938 | 30 | 148,111 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-08-19 | A | 4,938 | 5 | 24,739 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-08-19 | D | 25,111 | 28 | 691,808 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-25 | D | 463,289 | 0 | 0 | Common | Form 4 ↗ |
| Andrew Dudum | Director | 2026-08-27 | D | 977,566 | 0 | 0 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-09-02 | D | 3,458 | 28 | 97,965 | Common | Form 4 ↗ |
| Mike Chi | Chief Operating Officer | 2026-09-15 | D | 14,027 | 28 | 398,227 | Common | Form 4 ↗ |
| Mohamed Elshenawy | CTO | 2026-09-15 | D | 7,954 | 28 | 225,814 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-09-16 | D | 6,236 | 28 | 173,735 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-17 | D | 12,313 | 29 | 354,861 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-22 | D | 14,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-22 | D | 29,277 | 30 | 876,846 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-09-22 | A | 14,000 | 5 | 70,140 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-09-30 | D | 3,461 | 29 | 100,957 | Common | Form 4 ↗ |
| Yemi Okupe | Chief Financial Officer | 2026-10-01 | D | 2,000 | 30 | 59,400 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-10-14 | D | 3,461 | 29 | 100,577 | Common | Form 4 ↗ |
| Soleil Boughton | Chief Legal Officer | 2026-10-28 | D | 3,462 | 28 | 95,551 | Common | Form 4 ↗ |
Sources (255 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Mohamed Elshenawy. DEF 14A, filed 2026-04-28. Section “2025 Summary Compensation Table”. As printed: 60,869,746. View filing ↗
- Section 01, Andrew Dudum. DEF 14A, filed 2026-04-28. Section “2025 Summary Compensation Table” · page 48. As printed: 22,958,907. View filing ↗
- Section 01, Nader Kabbani. DEF 14A, filed 2026-04-28. Section “2025 Summary Compensation Table”. As printed: 14,862,305. View filing ↗
- Section 01, Yemi Okupe. DEF 14A, filed 2026-04-28. Section “2025 Summary Compensation Table”. As printed: 8,398,808. View filing ↗
- Section 01, Melissa Baird. DEF 14A, filed 2026-04-28. Section “2025 Summary Compensation Table”. As printed: 8,392,871. View filing ↗
- Section 01, Mike Chi. DEF 14A, filed 2026-04-28. Section “2025 Summary Compensation Table”. As printed: 7,727,713. View filing ↗
- Section 01, Soleil Boughton. DEF 14A, filed 2026-04-28. Section “2025 Summary Compensation Table”. As printed: 4,796,709. View filing ↗
- Section 03, Nader Kabbani RSU. DEF 14A, filed 2026-04-28. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Mohamed Elshenawy RSU. DEF 14A, filed 2026-04-28. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Yemi Okupe RSU. DEF 14A, filed 2026-04-28. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Mike Chi RSU. DEF 14A. Section “Executive Compensation” · grants of plan-based awards table.
- Section 03, Andrew Dudum RSU. DEF 14A, filed 2026-04-28. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Mike Chi RSU. DEF 14A, filed 2026-04-28. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Melissa Baird RSU. DEF 14A, filed 2026-04-28. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Soleil Boughton RSU. DEF 14A, filed 2026-04-28. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Andrew Dudum OPTION. DEF 14A, filed 2026-04-28. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Yemi Okupe RSU. DEF 14A. Section “Executive Compensation” · grants of plan-based awards table.
- Section 03, Yemi Okupe RSU. DEF 14A, filed 2026-04-28. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Mike Chi RSU. DEF 14A, filed 2026-04-28. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-28. Section “CEO Pay Ratio”. As printed: 272 : 1. View filing ↗
- Section 08, Deb Autor. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 305,931. View filing ↗
- Section 08, David Wells. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 274,579. View filing ↗
- Section 08, Christopher Payne. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 246,079. View filing ↗
- Section 08, Andrea Perez. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 241,931. View filing ↗
- Section 08, Anja Manuel. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 240,931. View filing ↗
- Section 08, Christiane Pendarvis. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 236,931. View filing ↗
- Section 08, Kåre Schultz. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 230,931. View filing ↗
- Section 08, Delos Cosgrove. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 226,931. View filing ↗
- Section 08, Patrick Carroll. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 226,931. View filing ↗
- Section 08, Andrew Dudum. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Kofi Amoo-Gottfried. DEF 14A, filed 2026-04-28. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Yemi Okupe 2026-05-18. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-05-18. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-05-18. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-05-20. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Wells 2026-05-20. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Payne 2026-05-20. Form 4, filed 2026-05-22. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Wells 2026-05-26. Form 4, filed 2026-05-26. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deb Autor 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Delos Cosgrove 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Delos Cosgrove 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Anja Manuel 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Anja Manuel 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christiane Pendarvis 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christiane Pendarvis 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Payne 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Payne 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deb Autor 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrea Perez 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrea Perez 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kåre Schultz 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kåre Schultz 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Wells 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Wells 2026-06-11. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Anja Manuel 2026-06-15. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Wells 2026-06-15. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-06-15. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Payne 2026-06-15. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Anja Manuel 2026-06-15. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deb Autor 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Payne 2026-06-15. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Payne 2026-06-15. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Payne 2026-06-15. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-06-15. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Wells 2026-06-15. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mohamed Elshenawy 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mohamed Elshenawy 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mohamed Elshenawy 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mohamed Elshenawy 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deb Autor 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deb Autor 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-06-16. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-06-17. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mohamed Elshenawy 2026-06-17. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-06-17. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-06-18. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-06-18. Form 4, filed 2026-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-06-22. Form 4, filed 2026-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-06-22. Form 4, filed 2026-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-06-22. Form 4, filed 2026-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-07-06. Form 4, filed 2026-07-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-07-06. Form 4, filed 2026-07-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-07-06. Form 4, filed 2026-07-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-07-17. Form 4, filed 2026-07-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-07-17. Form 4, filed 2026-07-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-07-17. Form 4, filed 2026-07-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Delos Cosgrove 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kofi Amoo-Gottfried 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrea Perez 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Wells 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Wells 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kofi Amoo-Gottfried 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Payne 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deb Autor 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Anja Manuel 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Payne 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kåre Schultz 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mohamed Elshenawy 2026-08-12. Form 4, filed 2026-08-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mohamed Elshenawy 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mohamed Elshenawy 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mohamed Elshenawy 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deb Autor 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Payne 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Payne 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Irene Becklund 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mohamed Elshenawy 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mohamed Elshenawy 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Wells 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Wells 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deb Autor 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Carroll 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kåre Schultz 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kåre Schultz 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deb Autor 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-08-14. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-08-17. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-08-17. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-08-17. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deb Autor 2026-08-18. Form 4, filed 2026-08-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-08-19. Form 4, filed 2026-08-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-08-19. Form 4, filed 2026-08-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-08-19. Form 4, filed 2026-08-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-08-19. Form 4, filed 2026-08-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-08-25. Form 4, filed 2026-08-27. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew Dudum 2026-08-27. Form 4, filed 2026-08-27. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-09-02. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mike Chi 2026-09-15. Form 4, filed 2026-09-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mohamed Elshenawy 2026-09-15. Form 4, filed 2026-09-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-09-16. Form 4, filed 2026-09-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-09-17. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-09-22. Form 4, filed 2026-09-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-09-22. Form 4, filed 2026-09-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-09-22. Form 4, filed 2026-09-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-09-30. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yemi Okupe 2026-10-01. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-10-14. Form 4, filed 2026-10-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Soleil Boughton 2026-10-28. Form 4, filed 2026-10-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-06-15. Item 5.07 · say-on-pay result. As reported: 99.26% (votes for as printed: 1,506,477,171). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-06-17. Item 5.07 · say-on-pay result. As reported: 98.3% (votes for as printed: 1,528,328,634). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-06-10. Item 5.07 · say-on-pay result. As reported: 97.28% (votes for as printed: 1,517,206,862). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 473,796 + equity 1,682,379 + all other 75,000 = 2,231,175, summed across the director compensation table rows.
- Alteryx, Section 10b CEO total. DEF 14A, filed 2023-04-04. CEO total compensation as printed in Alteryx's own proxy. As printed: 57,191,521. View filing ↗
- Elastic NV, Section 10b CEO total. DEF 14A, filed 2026-08-28. CEO total compensation as printed in Elastic NV's own proxy. As printed: 46,961,904. View filing ↗
- Coursera, Section 10b CEO total. DEF 14A, filed 2026-05-11. CEO total compensation as printed in Coursera's own proxy. As printed: 39,387,371. View filing ↗
- Hims & Hers Health (subject), Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Hims & Hers Health's own proxy. As printed: 22,958,907. View filing ↗
- Five9, Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Five9's own proxy. As printed: 17,403,709. View filing ↗
- PagerDuty, Section 10b CEO total. DEF 14A, filed 2026-05-04. CEO total compensation as printed in PagerDuty's own proxy. As printed: 15,268,028. View filing ↗
- Privia Health Group, Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Privia Health Group's own proxy. As printed: 10,472,698. View filing ↗
- Yelp, Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Yelp's own proxy. As printed: 10,256,932. View filing ↗
- Smartsheet, Section 10b CEO total. DEF 14A, filed 2024-05-01. CEO total compensation as printed in Smartsheet's own proxy. As printed: 10,205,886. View filing ↗
- Rapid7, Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in Rapid7's own proxy. As printed: 10,058,576. View filing ↗
- CarGurus, Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in CarGurus's own proxy. As printed: 7,889,260. View filing ↗
- Bumble, Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Bumble's own proxy. As printed: 7,617,828. View filing ↗
- Jamf Holding, Section 10b CEO total. DEF 14A, filed 2025-04-29. CEO total compensation as printed in Jamf Holding's own proxy. As printed: 7,106,371. View filing ↗
- Udemy, Section 10b CEO total. DEF 14A, filed 2025-04-25. CEO total compensation as printed in Udemy's own proxy. As printed: 5,151,396. View filing ↗
- Sprinklr, Section 10b CEO total. DEF 14A, filed 2026-05-01. CEO total compensation as printed in Sprinklr's own proxy. As printed: 1,664,700. View filing ↗
- DigitalOcean, Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in DigitalOcean's own proxy. As printed: 1,210,795. View filing ↗
- EngageSmart, Section 10b CEO total. DEF 14A, filed 2023-04-05. CEO total compensation as printed in EngageSmart's own proxy. As printed: 958,500. View filing ↗
- Duolingo, Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Duolingo's own proxy. As printed: 767,500. View filing ↗
- Box, Section 10b CEO total. DEF 14A, filed 2026-05-13. CEO total compensation as printed in Box's own proxy. As printed: 257,076. View filing ↗
- Section 10a, Alteryx reciprocity. DEF 14A. Alteryx's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Privia Health Group reciprocity. DEF 14A. Privia Health Group's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Jamf Holding reciprocity. DEF 14A. Jamf Holding's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Smartsheet reciprocity. DEF 14A. Smartsheet's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Udemy reciprocity. DEF 14A. Udemy's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Coursera reciprocity. DEF 14A. Coursera's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Bumble reciprocity. DEF 14A. Bumble's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Box reciprocity. DEF 14A. Box's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Duolingo reciprocity. DEF 14A. Duolingo's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Elastic N.V. reciprocity. DEF 14A. Elastic N.V.'s most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Five9 reciprocity. DEF 14A. Five9's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, PagerDuty reciprocity. DEF 14A. PagerDuty's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Rapid7 reciprocity. DEF 14A. Rapid7's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, SentinelOne reciprocity. DEF 14A. SentinelOne's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Sprinklr reciprocity. DEF 14A. Sprinklr's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗
- Section 10a, Yelp reciprocity. DEF 14A. Yelp's most recent proxy was read; its disclosed peer group does not include Hims & Hers Health. View filing ↗